Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;75(3):195-200.
doi: 10.1007/BF01258630.

Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain

F Fadda  1 , G L Gessa, E Mosca, E Stefanini
Affiliations

Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain

F Fadda et al. J Neural Transm. 1989.

Abstract

The effect of two calcium antagonists, nimodipine and flunarizine, on striatal dopamine (DA) metabolism in rats was compared. Flunarizine (5-20 mg/kg i.p.) caused a dose-dependent increase in the DA metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC) in the caudate nucleus. Following the 20 mg/kg dose, DOPAC levels were maximally elevated by about 50% from 2 to 12 hrs after treatment. On the contrary, nimodipine at the dose of 20 mg/kg i.p. produced a modest decrease in DOPAC levels. Neither calcium antagonist modified DA content. However, both nimodipine and flunarizine, at the dose of 20 mg/kg, markedly reduced the accumulation of DOPAC in the caudate nucleus induced by haloperidol (1 mg/kg). It is suggested that flunarizine, but not nimodipine, has a neuroleptic-like action, whereas the two calcium antagonists have in common the ability to attenuate the hyperactivity of DA neurons.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. J Neural Transm. 1987;68(3-4):241-55 - PubMed
    1. Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(2-3):165-73 - PubMed
    1. Life Sci. 1983 Dec 12;33(24):2387-97 - PubMed
    1. Life Sci. 1986 Jun 30;38(26):2375-81 - PubMed
    1. Neuropharmacology. 1987 Jan;26(1):101-5 - PubMed

LinkOut - more resources